Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Methodological issues in tardive dyskinesia research.

H A Nasrallah

    Schizophrenia Bulletin
    |January 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Tardive dyskinesia research yields conflicting results due to inconsistent methods. Developing patient pharmacological response profiles could lead to distinct subtypes and targeted treatments for this neuroleptic-induced movement disorder.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Impact of desertification on temperature trends in the Middle East.

    Environmental monitoring and assessment·2013
    Same author

    Renaming schizophrenia: keeping up with the facts.

    Schizophrenia research·2013
    Same author

    Persistent infection with neurotropic herpes viruses and cognitive impairment.

    Psychological medicine·2012
    Same author

    Protection from olanzapine-induced metabolic toxicity in mice by acetaminophen and tetrahydroindenoindole.

    International journal of obesity (2005)·2010
    Same author

    Linkage analysis of schizophrenia in African-American families.

    Schizophrenia research·2009
    Same author

    Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles.

    Molecular psychiatry·2007
    Same journal

    Reconsidering the Term "Treatment Resistant Schizophrenia".

    Schizophrenia bulletin·2026
    Same journal

    The Effect of Semaglutide on Antipsychotic-Induced Weight Gain and Other Metabolic Parameters, among a Cohort of Inpatients.

    Schizophrenia bulletin·2026
    Same journal

    Comparing Apples to Oranges Obscures Tortoises Beating Hares: The Relationship Between Rate of Antipsychotic Tapering and Relapse.

    Schizophrenia bulletin·2026
    Same journal

    Beyond the Need for Speed: D2 Receptor Affinity Predicts Relapse after Antipsychotic Tapering in First Episode Psychosis.

    Schizophrenia bulletin·2026
    Same journal

    Correction to: The Mini-CAARMS: Development and Validation of a Short Version of the Comprehensive Assessment of AT Risk Mental States to Facilitate Preventive Psychiatry.

    Schizophrenia bulletin·2026
    Same journal

    Longitudinal Impact of Birthweight and its Polygenic Risk Score on Glucose and Antipsychotic-Induced Weight Gain in First Episode Psychosis.

    Schizophrenia bulletin·2026
    See all related articles

    Area of Science:

    • Neurology
    • Pharmacology
    • Movement Disorders

    Background:

    • Tardive dyskinesia (TD) is an involuntary movement disorder resulting from long-term neuroleptic medication.
    • Current research on TD has produced inconsistent findings and lacks clear clinical utility.
    • Methodological heterogeneity, including diagnostic criteria, study designs, and rating scales, contributes to research variability.

    Purpose of the Study:

    • To address the inconsistencies in tardive dyskinesia research.
    • To propose a strategy for generating more meaningful and clinically applicable data.
    • To identify potential pharmacological and clinical subtypes of tardive dyskinesia.

    Main Methods:

    • The study critiques existing research methodologies in tardive dyskinesia.

    Related Experiment Videos

  • It proposes a novel strategy focusing on pharmacological response profiles of patients.
  • The approach aims to delineate patient subgroups based on their drug responses.

    • Main Results:

    • Conflicting results in current tardive dyskinesia research are attributed to methodological inconsistencies.
    • A proposed strategy of developing pharmacological response profiles offers a path toward more robust findings.
    • This approach may enable the identification of distinct patient subtypes.

    Conclusions:

    • Standardizing research methodologies is crucial for advancing tardive dyskinesia understanding.
    • Developing pharmacological response profiles can help stratify patients into clinically relevant subtypes.
    • This strategy holds promise for guiding personalized treatment approaches for tardive dyskinesia.